Tag Archives: drug legislation

Affordable Care Act, Benefit Managers, Pharmacy Benefit Managers

Dr. Vogenberg on Regulatory and Legislative Changes Effect on Healthcare, P&T Committees

Posted on by John Santilli
25
Jan

AMI founding partner Dr. Randy Vogenberg recently co-authored an article for Pharmacy & Therapeutics (P&T)’s January 2018 issue entitled “Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery”.  The article explores high-level trends of the Trump administration’s policy, legislative agenda, and regulations, focusing on FDA policies that may affect drug prices and relaxation of the […]

Continue reading →
Dr. Randy Vogenberg, Market Intelligence

Biosimilar Confusion and Insights

Posted on by Dr. Randy

Since Virginia became the first state in May 2013 to enact legislation regulating a pharmacist’s substitution of an interchangeable biologic drug for a prescribed reference biologic drug, there has not been much activity or clarity on the issue. This issue continues to pit manufacturer versus manufacturer, and other stakeholders against each other in the policy […]

Continue reading →